 |
 |
PRESS RELEASE: "5th International Neurodegeneration in Alzheimer's, Parkinson's & Other Related Disorders" Conference PHILADELPHIA, May 4 /PRNewswire/ -- The "5th International Neurodegeneration in Alzheimer's, Parkinson's & Other Related Disorders" conference will feature on a variety of topics including drug candidates & novel targets in neurodegeneration associated with AD, Parkinson's & ischaemic stroke, announces Strategic Research Institute. The annual conference is part of the Annual CNS Diseases Congress which will take place June 28-29, 2004 in Philadelphia, PA. The conference will feature other tracks which include Psychiatric Disorders. Some of the topics highlighted include schizophrenia, anxiety, depression, bipolar and other related disorders. The other track will focus on CNS Clinical Trials and Drug Development issues. The meeting focuses on applied efforts, which will feature presentations of novel work by a rich variety of pharmaceutical, biotech, academic and government scientists and senior-management executives engaged in cutting edge work in these fields. The agenda will feature 3 concurrent tracks with over 45+ presentations covered over two days. Attendees who register for the conference will have access to the entire congress that includes all conference sessions, networking and social functions. To register/request a copy of the agenda in PDF format, please contact Glenn Pascual at [log in to unmask] Please include your full contact information so a hard copy can be sent to your attention as well. Alternatively, you can view the conference agenda online at http://www.srinstitute.com/CNS To become a conference sponsor or exhibitor, please contact Mark Alexay at [log in to unmask] or 212.967.0095, x251 SOURCE Strategic Research Institute Web Site: http://www.srinstitute.com http://www.srinstitute.com/CNS SOURCE: PR Newswire (press release) http://tinyurl.com/ypzsd * * * ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn